Depo Provera: still controversial.
Wren
L M
LM
D000569:Americas; D000830:Animals, Laboratory; D001695:Biology; D001943:Breast Neoplasms; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D003906:Developing Countries; D004194:Disease; D004467:Economics; D004703:Endocrine System; D005193:Family Planning Services; D006077:Government Agencies; D006728:Hormones; D017258:Medroxyprogesterone Acetate; D009369:Neoplasms; D009656:North America; D009938:Organizations; D010827:Physiology; D011057:Politics; D012102:Reproductive Control Agents; D012106:Research; D013672:Technology; D014481:United States
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D006728:Hormones; D012102:Reproductive Control Agents; D017258:Medroxyprogesterone Acetate
Americas; Animals, Laboratory; Biology; Breast Cancer; Cancer; Clinical Research; Contraception; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Depo-provera--side effects; Developed Countries; Developing Countries; Diseases; Economic Factors; Endocrine System; Family Planning; Government Agencies--standards; Hormones; Medroxyprogesterone Acetate--side effects; Neoplasms; North America; Northern America; Organizations; Physiology; Political Factors; Reproductive Control Agents; Research And Development; Research Methodology; Technology; United States